Who are Daya CNS's investors?

Daya CNS's investors include BioGenerator Ventures.

How much funding has Daya CNS raised?

Daya CNS has disclosed $228.3K raised across 1 round.

Where is Daya CNS headquartered?

Daya CNS is headquartered in Saint Louis, US.

Daya CNS

Saint Louis, US · Founded 2013 · Missouri LLC · 1 known investors

Find your way into Daya CNS

Paths you didn't know you had: your email and LinkedIn already hold routes to the Daya CNS team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Daya CNS is a pharmaceutical company focused on drug discovery and development for central nervous system disorders, with expertise in small molecule therapeutics targeting pain and related conditions.

Biotech Healthtech Medical Devices

Founders & leadership

Raj DevrajNamed on SEC filing

Walter SmithNamed on SEC filing

Steve HanleyChairman of the Board

Ragahavan RajagopalanNamed on SEC filing

Raghavan RajagopalanChief Scientific Officer

Jeffrey BooneGeneral Counsel

Terence SternChief Financial Officer

Investors · 1

BioGenerator Ventureslisted by BioGenerator VenturesSt. Louis · $50K – $250K

How we know: BioGenerator Ventures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$228.3K disclosed across 1 round · 2015

▶$228.3KraisedNov 2016 · 7 investors · Pharmaceuticals

Rule 506(c)

Officers, directors & promoters on the filing

Raj DevrajDirector
Walter SmithDirector
Steve HanleyDirector
Ragahavan RajagopalanExecutive Officer, Director

Offering amount: $228.3K
Amount sold: $228.3K
First sale: Aug 2015
Incorporated: Limited Liability Company, Missouri, 2013
Federal exemptions: 06c

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Daya CNS do?: Daya CNS is a pharmaceutical company focused on drug discovery and development for central nervous system disorders, with expertise in small molecule therapeutics targeting pain and related conditions.
Who are Daya CNS's investors?: Daya CNS's investors include BioGenerator Ventures.
How much funding has Daya CNS raised?: Daya CNS has disclosed $228.3K raised across 1 round.
Where is Daya CNS headquartered?: Daya CNS is headquartered in Saint Louis, US.